Eli Lilly reports results from Covid-19 phase 2 antibody drug trial
Previously, the suspension of trials of a vaccine against coronavirus was announced by Johnson Johnson
Another pharmaceutical company suspends testing of an experimental drug for COVID-19 for safety reasons.
US-based Eli Lilly announced that clinical trials of its coronavirus antiviral drug had been suspended by independent observers "as a precautionary measure," but did not elaborate..
The day before, American drug maker Johnson Johnson suspended large-scale clinical trials of an experimental vaccine after one of the participants was diagnosed with an unexplained illness..